Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies

BACKGROUND: Immune-related adverse events (irAEs) are frequently reported during immune checkpoint inhibitor (ICI) therapy and are associated with long-term outcomes. It is unknown if the irAE occurrence is a valid surrogate of ICIs’ efficacy. METHODS: We identified articles reporting the results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoroso, V., Gallo, F., Alberti, A., Paloschi, D., Ferrari Bravo, W., Esposito, A., Cosentini, D., Grisanti, S., Pedersini, R., Petrelli, F., Berruti, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984799/
https://www.ncbi.nlm.nih.gov/pubmed/36842300
http://dx.doi.org/10.1016/j.esmoop.2023.100787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984799/
https://www.ncbi.nlm.nih.gov/pubmed/36842300
http://dx.doi.org/10.1016/j.esmoop.2023.100787

Ejemplares similares